Drug Controller General of India has written to state drug regulators, asking them to alert manufacturers about Ranitidine & take steps to ensure patient safety.
Alert was issued on insulin pumps made by American medical equipment giant Medtronic. In India, the insulin pumps used are MiniMed 508 and MiniMed Paradigm series.
Bottle of Lies by journalist Katherine Eban accuses Indian pharma firms of fudging data on quality control and toxic impurities, among other major lapses.
The drugs — eszopiclone (Lunesta), zaleplon (Sonata) and zolpidem (Ambien, Ambien CR, Edluar, Intermezzo, and Zolpimist) — are commonly prescribed in India too.
MGNREGA empowered citizens to engage the state on equal terms. VB-GRAMG recasts them as labharthis, who must prove eligibility to receive the largesse of a benevolent leader.
RBI Handbook of Statistics shows state’s GSDP has more than doubled in past decade, finishing second behind Maharashtra. It has performed well across health & education parameters as well.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS